Current status of surgery for pancreatic cancer

Digestive Surgery

Volumn 24, Issue 2, 2007, Pages 137-147

  Hirata, Koichi ^a,c   Egawa, Shinichi ^b   Kimura, Yasutoshi ^a   Nobuoka, Takayuki ^a   Oshima, Hidenori ^a   Katsuramaki, Tadashi ^a   Mizuguchi, Toru ^a   Furuhata, Tomohisa ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c NONE   (Japan)

Author keywords

Pancreatic cancer, incidence; Surgery, pancreatic cancer

Indexed keywords

CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; ECHOGRAPHY; EUROPE; GENE MUTATION; HUMAN; INTERMETHOD COMPARISON; INVASIVE CARCINOMA; JAPAN; LAPAROSCOPY; LIVER METASTASIS; LYMPH NODE METASTASIS; MEDICAL ASSESSMENT; MEDICAL LITERATURE; MEDICAL SOCIETY; MICROMETASTASIS; MORBIDITY; MULTIDETECTOR COMPUTED TOMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PANCREAS CARCINOMA; PANCREAS RESECTION; PUBLICATION; REVIEW; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA; STANDARD; SUPERIOR MESENTERIC VEIN; SURGICAL TECHNIQUE; SURVIVAL TIME; TREATMENT INDICATION; TREATMENT OUTCOME; UNITED STATES; VEIN SURGERY;

HUMANS; JAPAN; PANCREATECTOMY; PANCREATIC NEOPLASMS;

EID: 34248998809     PISSN: 02534886     EISSN: None     Source Type: Journal    
DOI: 10.1159/000102067     Document Type: Review

References (64)

1. Pancreatic Cancer Registration Committee in Japan Pancreas Society. Pancreatic cancer registration of JPS: the summary for 20 years (in Japanese). J Jpn Pancreas Soc 2003;18:101-169.
2. Ishikawa O, Ohhigashi H, Sasaki Y, Kabuto T, Fukuda I, Furukawa H, Imaoka S, Iwanaga T: Practical usefulness of lymphatic and connective tissue clearance for carcinoma of the pancreas head. Ann Surg 1988;208:215-220.
3. Nagakawa T, Nagamori M, Futakami F, Tsukioka Y, Kayahara M, Ohta T, Ueno K, Miyazaki I: Results of extensive surgery for pancreatic carcinoma. Cancer 1996;77:640-645.
4. Takahashi S, Ogata Y, Miyazaki H, Maeda D, Murai S, Yamataka K, Tsuzuki T: Aggressive surgery for pancreatic duct cell cancer: feasibility, validity, limitations. World J Surg 1995;19:653-659.
5. Nitecki SS, Sarr MG, Colby TV, van Heerden JA: Long-term survival after resection for ductal adenocarcinoma of the pancreas. Ann Surg 1995;221:59-66.
6. Sener SF, Fremgen A, Menck HR, Winchester DP: Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the national cancer database. J Am Coll Surg 1999;189:1-7.
7. Trede M, Schwall J, Cameron J: Improved hospital morbidity, mortality and survival after the Whipple procedure. Ann Surg 1987;206:358-365.
8. Neoptolemos JP, Stocken DD, Friess H, Bassi C, Dunn JA, Hickey H, Beger H, Fernandez-Cruz L, Dervenis C, Lacaine F, Falconi M, Pederzoli P, Pap A, Spooner D, Kerr DJ, Buchler MW: A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 2004;350:1200-1210.
9. Kim HJ, Czischke K, Brennan MF, Conlon KC: Does neoadjuvant chemoradiation downstage locally advanced pancreatic cancer? J Gastrointest Surg 2002;6:763-769.
10. Klinkenbijl JH, Jeekel J, Sahmoud T, van Pel R, Couvreur ML, Veenhof CH, Arnaud JP, Gonzalez DG, de Wit LT, Hennipman A, Wils J: Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group. Ann Surg 1999;230:776-784.
11. Takada T, Amano H, Yasuda H, Nimura Y, Matsushiro T, Kato H, Nagakawa T, Nakayama T: Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma. Cancer 2002;95:1685-1695.
12. Ichikawa T, Haradome H, Hachiya J, Nitatori T, Ohtomo K, Kinoshita T, Araki T: Pancreatic ductal adenocarcinoma preoperative assessment with helical CT versus dynamic MR imaging. Radiology 1997;202:655-662.
13. Oshikawa O, Tanaka S, Ioka T, Nakaizumi A, Hamada Y, Mitani T: Dynamic sonography of pancreatic tumors: comparison with dynamic CT. AJR Am J Roentgenol 2002;178:1133-1137.
14. Saisho H, Yamaguchi T: Diagnostic imaging for pancreatic cancer, computed tomography, magnetic resonance imaging, and positron emission tomography. Pancreas 2004;28:273-278.
15. Vargas R, Nino-Murcia M, Trueblood W, Jeffrey RB Jr: MDCT in pancreatic adenocarcinoma: prediction of vascular invasion and respectability using a multiphasic technique with curved planner reformations. AJR Am J Roentgenol 2004;182:419-425.
16. Scaglione M, Pinto A, Romano S, Scialpi M, Volterrani L, Rotondo A, Romano L: Using multidetector row computed tomography to diagnose and stage pancreatic carcinoma: the problems and the possibilities. JOP 2005;13;6:1-5.
17. Glasbrenner B, Schwarz M, Pauls S, Preclik G, Beger HG, Adler G: Prospective comparison of endoscopic ultrasound and endoscopic retrograde cholangiopancreatography in the preoperative assessment of masses in the pancreatic head. Dig Surg 2000;17:468-474.
18. Kaneko T, Nakao A, Inoue S, Harada A, Nonami T, Itoh S, Endo T, Takagi H: Intraportal endovascular ultrasonography in the diagnosis of portal vein invasion by pancreatobiliary carcinoma. Ann Surg 1995;222:711-718.
19. Sobin LH, Wittekind C (eds): International Union Against Cancer. TNM Classification of Malignant Tumors, ed 6. New York, Wiley-Liss, 2002.
20. Wray CJ, Ahmad SA, Matthews JB, Lowy AM: Surgery for pancreatic cancer: Recent controversies and current practice. Gastroenterology 2005;128:1626-1641.
21. Tada M, Omata M, Kawai S, Saisho H, Ohto M, Saiki RK, Sninsky JJ: Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma. Cancer Res 1993;53:2472-2474.
22. Inoue S, Nakao A, Kasai Y, Harada A, Nonami T, Takagi H: Detection of hepatic micrometastasis in pancreatic adenocarcinoma patients by two-stage polymerase chain reaction/ restriction fragment length polymorphism (PCR/RFLP) analysis. Jpn J Cancer Res 1995;86:626-630.
23. Nomoto S, Nakao A, Kasai Y, Harada A, Nonami T, Takagi H: Detection of ras gene mutations in peripheral blood with pancreatic adenocarcinoma. Jpn J Cancer Res 1996;87:793-797.
24. Tamagawa E, Ueda M, Takahashi S, Sugano K, Uematsu S, Mukai M, Ogata Y, Kitajima M: Pancreatic lymph nodal and plexus micrometastases detected by enriched polymerase chain reaction and nonradioisotopic single-strand conformation polymorphism analysis: a new predictive factor for recurrent pancreatic carcinoma. Clin Cancer Res 1997;3:2143-2149.
25. Ando N, Nakao A, Nomoto S, Takeda S, Kaneko T, Kurokawa T, Nonami T, Takagi H: Detection of mutant K-ras in dissected paraaortic lymph nodes of patients with pancreatic adenocarcinoma. Pancreas 1997;15:374-378.
26. Funaki NO, Tanaka J, Hosotani R, Kogire M, Suwa H, Imamura M: Quantitative analysis of carcinoembryonic antigen messenger RNA in peripheral venous blood and portal blood of patients with pancreatic ductal adenocarcinoma. Clin Cancer Res 1998;4:855-860.
27. Aihara T, Noguchi S, Ishikawa O, Furukawa H, Hiratsuka M, Ohigashi H, Nakamori S, Monden M, Imaoka S: Detection of pancreatic and gastric cancer cells in peripheral and portal blood by amplification of keratin 19 mRNA with reverse transcriptase-polymerase chain reaction. Int J Cancer 1997;72:408-411.
28. Miyazono F, Takao S, Natsugoe S, Uchikura K, Kijima F, Aridome K, Shinchi H, Aikou T: Molecular detection of circulating cancer cells during surgery in patients with biliary-pancreatic cancer. Am J Surg 1999;177:475-479.
29. Kuroki T, Tomioka T, Tajima Y, Inoue K, Ikematsu Y, Ichinose K, Furui J, Kanematsu T: Detection of the pancreas-specific gene in the peripheral blood of patients with pancreatic carcinoma. Br J Cancer 1999;81:350-353.
30. Ishizone S, Yamauchi K, Kawa S, Suzuki T, Shimizu F, Harada O, Sugiyama A, Miyagawa S, Fukuda M, Nakayama J: Clinical utility of quantitative RT-PCR targeted to alpha1,4-N-acetylglucosaminyltransferase mRNA for detection of pancreatic cancer. Cancer Sci 2006;97:119-126.
31. Isaji S, Kawarada Y, Uemoto S: Classification of pancreatic cancer: comparison of Japanese and UICC classifications. Pancreas 2004;28:231-234.
32. Kawarada Y, Das BC, Naganuma T, Isaji S: Surgical treatment of pancreatic cancer. Does extended lymphadenectomy provide a better outcome? J Hepatobiliary Pancreat Surg 2001;8:224-229.
33. Smeenk HG, Tran TCK, Erdmann J, Eijck CHJ, Jeekel J: Survival after surgical management of pancreatic adenocarcinoma: does curative and radical surgery truly exist? Langenbecks Arch Surg 2005;390:94-103.
34. Matsuno S, Egawa S, Fukuyama S, Motoi F, Sunamura M, Isaji S, Imaizumi T, Okada S, Kato H, Suda K, Nakao A, Hiraoka T, Hosotami R, Takeda K: Pancreatic Cancer Registry in Japan: 20 years of experience. Pancreas 2004;28:219-230.
35. Nakasako Y, Hanyu F, Takasaki K: Indications for extended radical and pylorus-preserving Whipple operation for pancreatic cancer; in Hanyu F, Takasaki K (eds): Pancreatoduodenectomy. Berlin, Springer, 1997, pp 99-106.
36. Hirata K, Sato T, Mukaiya M, Yamashiro K, Kimura M, Sasaki K, Denno R: Results of 1001 pancreatic resections for invasive ductal adenocarcinoma of the pancreas. Arch Surg 1997;132:771-777.
37. Mukaiya M, Hirata K, Satoh T, Kimura M, Yamashiro K, Ura H Oikawa I, Denno R: Lack of survival benefit of extended lymph node dissection for ductal adenocarcinoma of the head of the pancreas: retrospective multi-institutional analysis in Japan. World J Surg 1998;22:248-252.
38. Hiraoka T, Kanematsu K: Combined treatment of resection with intraoperative radiotherapy. Part 6: Tumors of the exocrine tissue: pancreatic cancer; in Beger HG, Warshaw AL, Buhler MW, Carr-Locke DL, Neoptolemos JP, Rusell C, Sarr MG (eds): The Pancreas. Oxford, Blackwell Science, 1998, pp 1085-1091.
39. Yeo CJ, Cameron JL, Lillemoe KD, Sohn TA, Campbell KA, Sauter PK, Coleman J, Abrams RA, Hruban RH: Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma. 2. Randomized control trial evaluating survival, morbidity, and mortality. Ann Surg 2002;236:355-368.
40. Pedrazzoli P, DiCarlo V, Dionigi R, Mosca F, Pederzoli P, Pasquali C, Kloppel G, Dhaene K, Michelassi F: Standard versus extended lymphadenectomy associated with pancreaticoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Ann Surg 1998;228:508-517.
41. Nagino M, Nimura Y: Does 'extended' surgery for pancreatic head adeno carcinoma have survival impact? (in Japanese). J Jpn Surg Soc 2006;107:173-176
42. Nakao A, Takeda S, Sakai M, Kaneko T, Inoue S, Sugimoto H, Kanazumi N: Extended radical resection versus standard resection for pancreatic cancer: the rationale for extended radical resection. Pancreas 2004;28:289-292.
43. Siriwardana HP, Siriwardena AK: Systematic review of outcome of synchronous portal-superior mesenteric vein resection during pancreatectomy for cancer. Br J Surg 2006;93:662-673.
44. Mimura H, Mori M, Hamazaki K, Tsuge H: Isolated pancreatectomy for ductal carcinoma of the head of the pancreas. Hepatogastroenterology 1994;41:483-488.
45. Takahashi S, Ogata Y, Miyazaki H, Maeda D, Mural S, Yamataka K, Tsuzuki T: Aggressive surgery for pancreatic duct cell cancer: feasibility, validity, limitations. World J Surg 1995;19:653-660.
46. Nakao A, Kaneko T, Takeda S, Inoue S, Harada A, Nomoto S, Ekmel T, Yamashita K, Hatsuno T: The role of extended radical operation for pancreatic cancer. Hepatogastroenterology 2001;48:949-952.
47. Imaizumi T, Hanyu F, Harada N, Hatori T, Fukuda A: Extended radical Whipple resection for cancer of the pancreatic head: operative procedure and results. Dig Surg 1998;15:299-307.
48. Ishikawa O, Ohigashi H, Sasaki Y, Nakano H, Furukawa H, Imaoka S, Takenaka A, Kasugai T, Ishiguro S: Intraoperative cytodiagnosis for detecting a minute invasion of the portal vein during pancteatoduodenectomy for adenocarcinoma of the pancreatic head. Am J Surg 1998;175:477-481.
49. Naganuma T, Isaji S, Kawarada Y: Staging and extended resection for pancreatic cancer. Pancreas 1998;16:355-362.
50. Shibata C, Kobari M, Tsuchiya T, Arai K, Anzai R, Takahashi M, Uzuki M, Sawai T, Yamazaki T: Pancreatectomy combined with superior mesenteric-portal vein resection for adenocarcinoma in pancreas. World J Surg 2001;25:1002-1005.
51. Kawada M, Kondo S, Okushiba S, Morikawa T, Katoh H: Reevaluation of the indications for radical pancreatectomy to contraindication? Surg Today 2002;32:598-601.
52. Aramaki M, Matsumoto T, Etoh T, Ishio T, Himeno Y, Sasaki A, Yada K, Kawano K, Kitano S: Clinical significance of combined pancreas and portal vein resection in surgery for pancreatic adenocarcinoma. Hepatogastroenterology 2003;50:263-266.
53. Nakagohri T, Kinoshita T, Konishi M, Inoue K, Takahashi S: Survival benefits of portal vein resection for pancreatic cancer. Am J Surg 2003;186:149-153.
54. Fortner JG: Regional resection of cancer of the pancreas: a new surgical approach. Surgery 1973;73:307-320.
55. Fuhrman GM, Leach SD, Staley CA, Cusack JC, Charnsangavej C, Cleary KR, El-Naggar AK, Fenoglio CJ, Lee JE, Evans DB: Rationale for en bloc vein resection in the treatment of pancreatic adenocarcinoma adherent to the superior mesenteric-portal vein confluence. Pancreatic Tumor Study Group. Ann Surg 1996;223:154-162.
56. Imamura M, Doi R: Treatment of locally advanced pancreatic cancer: should we resect when resectable? Pancreas 2004;28:293-295.
57. Nakao A, Takagi H: Isolated pancreatectomy for pancreatic head carcinoma using catheter bypass of the portal vein. Hepatogastroenterology 1993;40:426-429.
58. Kobayashi S, Asano T, Ochiai T: A proposal of no-touch isolation technique in pancreatoduodenectomy for periampullary carcinomas. Hepatogastroenterology 2001;48:372-374.
59. Hirota M, Shimada S, Yamamoto K, Tanaka E, Sugita H, Egami H, Ogawa M: Pancreatectomy using the no-touch isolation technique followed by extensive intraoperative peritoneal lavage to prevent cancer cell dissemination: a pilot study. J Pancreat 2005;6:143-151.
60. Birkmeyer JD, Siewers AE, Finlayson EVA, Stukel TA, Lucas FL, Batista I, Welch G, Wennberg DE: Hospital volume and surgical mortality in the United States. N Engl J Med 2002;346:1128-1137.
61. Birkmeyer JD, Stukel TA, Siewers AE, Goodney PP, Wennberg DE, Lucas FL: Surgeon volume and operative mortality in the United States. N Engl J Med 2003;349:2117-2127.
62. Gouma DJ, van Greenen RCI, van Gulik TM, de Haan RJ, de Wit LT, Busch ORC, Obertop H: Rates of complications and death after pancreaticoduodenectomy: risk factors and the impact of hospital volume. Ann Surg 2000;232:786-795.
63. Rosemurgy AS, Bloomston M, Serafini FM, Coon B, Murr M, Carey LC: Frequency with which surgeons undertake pancreaticoduodenectomy determines length of stay, hospital charges, and in-hospital mortality. J Gastrointest Surg 2001;5:21-26.
64. Van Heek NT, Kuhlmann KFD, Scholten RJ, de Castro SM, Busch OR, van Gulik TM, Obertop H, Gouma DJ: Hospital volume and mortality after pancreatic resection. A systematic review and an evaluation of intervention in the Netherlands. Ann Surg 2005;242:781-790.